Date Modified

2024-01-08

Period

12/months

Report Summary

• Trial commenced on 01.07.2022 • Recruitment status: recruitment complete: follow up complete • Number assessed for eligibility: 173 for PD and 156 for epilepsy • Number recruited and allocated/randomized: 46 for PD and 45 for epilepsy • Final sample size: 43 for PD and 40 for epilepsy • Date of trial completion: 29.03.2023

Attached file